LRP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.657400E-01
Normal-vs-Stage2
5.396200E-01
Normal-vs-Stage3
6.501400E-01
Normal-vs-Stage4
1.722050E-01
Stage1-vs-Stage2
1.592640E-01
Stage1-vs-Stage3
3.659800E-02
Stage1-vs-Stage4
8.503000E-01
Stage2-vs-Stage3
1.519960E-01
Stage2-vs-Stage4
1.611990E-01
Stage3-vs-Stage4
5.236100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.124200E-01
Normal-vs-AfricanAmerican
1.838610E-01
Normal-vs-Asian
9.105600E-01
Caucasian-vs-AfricanAmerican
3.723800E-01
Caucasian-vs-Asian
3.097600E-01
AfricanAmerican-vs-Asian
9.496300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.498400E-01
Normal-vs-Female
4.427000E-01
Male-vs-Female
9.099400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.302200E-01
Normal-vs-Age(41-60Yrs)
3.202000E-01
Normal-vs-Age(61-80Yrs)
5.956400E-01
Normal-vs-Age(81-100Yrs)
8.901400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.117800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.851000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.134800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.460400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.161230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.532800E-01
Normal-vs-Daily Drinker
6.641600E-01
Normal-vs-Weekly Drinker
6.871200E-01
Normal-vs-Occasional Drinker
3.242800E-01
Normal-vs-Social Drinker
3.183200E-01
Non Drinker-vs-Daily Drinker
1.818000E-02
Non Drinker-vs-Weekly Drinker
8.175200E-01
Non Drinker-vs-Occasional Drinker
1.545580E-01
Non Drinker-vs-Social Drinker
1.395770E-01
Daily Drinker-vs-Weekly Drinker
1.813010E-01
Daily Drinker-vs-Occasional Drinker
4.758900E-03
Daily Drinker-vs-Social Drinker
9.318700E-03
Weekly Drinker-vs-Occasional Drinker
4.726800E-01
Weekly Drinker-vs-Social Drinker
3.870400E-01
Occasional Drinker-vs-Social Drinker
7.792800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.390400E-02
Normal-vs-Grade 2
1.566480E-02
Normal-vs-Grade 3
2.003600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.305400E-01
Grade 1-vs-Grade 3
9.182200E-01
Grade 1-vs-Grade 4
4.390400E-02
Grade 2-vs-Grade 3
1.324410E-01
Grade 2-vs-Grade 4
1.566480E-02
Grade 3-vs-Grade 4
2.003600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.030400E-01
Normal-vs-NonDiabetic
5.397600E-01
Diabetic-vs-NonDiabetic
4.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.394600E-01
Normal-vs-NoPancreatitis
5.790800E-01
Pancreatitis-vs-NoPancreatitis
7.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.415800E-01
Normal-vs-N1
5.044800E-01
N0-vs-N1
9.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.166000E-01
Normal-vs-TP53-NonMutant
2.503400E-01
TP53-Mutant-vs-TP53-NonMutant
3.193600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
